Ftse Mib
37.736,16
-3,41%
DAX
22.326,81
-3,51%
S&P 500
5.778,15
-1,22%
NASDAQ
18.285,16
-0,35%
Bitcoin
87.100,87
-0,15%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Hikma Pharmaceuticals Plc (HIK) Hikma Pharmaceuticals Plc (HIK) Notizie

Hikma Pharmaceuticals Plc

HIK
2.158,00
-18,00 (-0,83%)
04 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
04/3/202512:16LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
26/2/202510:03ALNCNewsHikma Pharmaceuticals to up R&D spend to support pipeline..
26/2/202508:00LSEG_RNSHikma Pharmaceuticals Plc Final Results
24/2/202515:15ALNCNewsEARNINGS PREVIEW: Hikma Pharmaceuticals set for slowed..
10/2/202509:09LSEG_RNSHikma Pharmaceuticals Plc Notice of Results
14/1/202513:41PRNUSHikma announces exclusive commercial partnership with..
23/12/202410:46LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
07/11/202416:30LSEG_RNSHikma Pharmaceuticals Plc Outcome of Audit Tender Process
07/11/202411:59ALNCNewsHikma Pharmaceuticals reiterates full-year guidance amid..
07/11/202408:00LSEG_RNSHikma Pharmaceuticals Plc Trading Statement
24/10/202408:00LSEG_RNSHikma Pharmaceuticals Plc 2024 Annual General Meeting Update..
01/10/202410:45LSEG_RNSHikma Pharmaceuticals Plc Block listing Interim Review
24/9/202411:09LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
10/9/202410:09ALNCNewsHikma Pharmaceuticals completes acquisition of Xellia's FDF..
10/9/202408:00LSEG_RNSHikma Pharmaceuticals Plc Hikma completes Xellia acquisition
03/9/202413:46ALNCNewsIN THE KNOW: Berenberg sees "standout" year at Hikma's..
20/8/202418:15PRNUSHikma Pharmaceuticals participates in naloxone training..
15/8/202421:18PRNUSKLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from..
13/8/202411:16ALNCNewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 shares
13/8/202410:39LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
08/8/202412:33ALNCNewsHikma Pharmaceuticals raises guidance as first-half profit..
08/8/202408:00LSEG_RNSHikma Pharmaceuticals Plc Half-year Report
29/7/202417:08LSEG_RNSHikma Pharmaceuticals Plc Director Declaration
15/7/202408:00LSEG_RNSHikma Pharmaceuticals Plc Notice of Results
01/7/202415:47LSEG_RNSHikma Pharmaceuticals Plc Total Voting Rights
27/6/202414:47LSEG_RNSHikma Pharmaceuticals Plc Director Declaration
17/6/202410:14ALNCNewsHikma adds scale to US injectables business with Xellia..
17/6/202408:00LSEG_RNSHikma Pharmaceuticals Plc Hikma acquires Xellia’s assets
11/6/202414:05ALNCNewsIN THE KNOW: Citi lifts Hikma price target amid positive..
05/6/202415:53LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
09/5/202410:49LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
25/4/202415:28LSEG_RNSHikma Pharmaceuticals Plc Result of AGM
25/4/202411:15ALNCNewsHikma Pharmaceuticals backs outlook after making strong..
25/4/202408:00LSEG_RNSHikma Pharmaceuticals Plc Trading Statement
17/4/202411:42LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
15/4/202417:43LSEG_RNSHikma Pharmaceuticals Plc Hikma appoints new President of..
11/4/202411:58LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
02/4/202410:50LSEG_RNSHikma Pharmaceuticals Plc Block listing Interim Review
22/3/202410:21LSEG_RNSHikma Pharmaceuticals Plc Annual Financial Report and Notice..
13/3/202410:42LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
07/3/202414:52LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
Apertura: 2.184,00 Min: 2.156,00 Max: 2.184,00
Chiusura: 2.176,00

La tua Cronologia

LSE
HIK
Hikma Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci